Karen Knudsen, the CEO, talks about the mission of improving patient access and commercialization of cancer therapies, and the need to do it more quickly.

After spending her entire career working in cancer research, Karen Knudsen is now leading an organization with a bold and very specific mission.

Knudsen serves as the chief executive officer of the Parker Institute for Cancer Immunotherapy. And she says the institute is not looking for small gains.

“We are looking for cancer cures,” she tells Chief Healthcare Executive®. “That's what we are doing.”